Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Z Gastroenterol

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    July 2022
  1. KRUGER K, Rossol S, Krauth C, Buggisch P, et al
    Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2022 Jul 15. doi: 10.1055/a-1852-5713.
    PubMed     Abstract available


    June 2022
  2. TERGAST TL, Kordecki N, Ohlendorf V, Beier C, et al
    [Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin as a salvage regimen after Sofosbuvir + Velpatasvir + Voxilaprevir re-treatment failure].
    Z Gastroenterol. 2022;60:959-962.
    PubMed     Abstract available


    January 2022
  3. TREBICKA J, Louvet A, Arroyo V, Jalan R, et al
    Severe alcoholic hepatitis as precipitant for organ failure and ACLF.
    Z Gastroenterol. 2022;60:67-76.
    PubMed     Abstract available


    July 2021
  4. CORNBERG M, Sandmann L, Protzer U, Niederau C, et al

    Z Gastroenterol. 2021;59:691-776.
    PubMed    


  5. SANDMANN L, Petersen J, Cornberg M

    Z Gastroenterol. 2021;59:641-643.
    PubMed    


  6. JANSEN PL, van Leeuwen P, Sandmann L, Cornberg M, et al

    Z Gastroenterol. 2021;59:e80-e90.
    PubMed    


    June 2021
  7. SCURT FG, Bose K, Canbay A, Mertens PR, et al
    [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options].
    Z Gastroenterol. 2021;59:560-579.
    PubMed     Abstract available


    March 2021
  8. SIMON KG, Serfert Y, Buggisch P, Mauss S, et al
    [Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 - An analysis of 17093 patients from different real world registries].
    Z Gastroenterol. 2021;59:241-249.
    PubMed     Abstract available


    November 2020
  9. HUPPE D, Niederau C, Serfert Y, Hartmann H, et al
    [Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany].
    Z Gastroenterol. 2020 Nov 9. doi: 10.1055/a-1291-8518.
    PubMed     Abstract available


  10. SARRAZIN C, Zimmermann T, Berg T, Hinrichsen H, et al

    Z Gastroenterol. 2020;58:1110-1131.
    PubMed    


  11. SARRAZIN C, Zimmermann T, Zeuzem S

    Z Gastroenterol. 2020;58:1107-1108.
    PubMed    


    September 2020
  12. VERMEHREN J, Serfert Y, Cornberg M, Stoehr A, et al
    Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2020;58:841-846.
    PubMed     Abstract available


    May 2020
  13. BERNHARD B, Stickel F
    Successful fourth line treatment of a relapse patient with chronic hepatitis C virus infection genotype 3a using sofosbuvir, glecaprevir/pibrentasvir, and ribavirin: a case report.
    Z Gastroenterol. 2020;58:451-455.
    PubMed     Abstract available


  14. SEBODE M, Kloppenburg A, Aigner A, Lohse AW, et al
    Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment.
    Z Gastroenterol. 2020;58:431-438.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: